Recommendation of the President #HPP #48aa – Prevention of alcohol and other substance abuse among adolescents and young adults
Recommendation No. 180/2025 of 28 November 2025 of the President of the Agency for Health Technology Assessment and Tariff System on recommended medical technologies, activities carried out under health policy programs, and conditions for the implementation of these programs, concerning the prevention of alcohol and other psychoactive substance addiction among adolescents and young adults
The recommendation is an update of Recommendation No. 12/2020 of November 30, 2020, of the President of the Agency for Health Technology Assessment and Tariff System on recommended medical technologies, measures carried out as part of health policy programs and the conditions for implementing these programs, concerning the prevention of alcohol and other psychoactive substance addiction among adolescents and young adults, in accordance with Article 48aa(8) of the Act on healthcare services financed from public funds.
The recommendation contains a model solution for a given health problem – Prevention of alcohol and other psychoactive substance addiction among adolescents and young adults.
The recommendation exempts local government units from the obligation to submit a health policy program prepared in accordance with its content for review.
Thus, the recommendation serves as a model for programs prepared by local government units to address this health problem.
The President of the Agency recommends that health policy programs include educational activities for the general population, educational activities for school-age youth, and training for parents or legal guardians of these children, training for medical personnel and teaching staff, clinical assessment of the youth population (11-18 years old) or young adults (19-30 years old) aimed at identifying people addicted to psychoactive substances and conducting anti-addiction interventions among participants with symptoms of addiction.
The President of the Agency does not recommend the use of other medical technologies and activities within the framework of health policy programs, as well as different implementation conditions than those included in this document.
Therefore, from November 28, 2025, in order to prepare PPZs for the prevention and early detection of postpartum depression, the provisions of Recommendation No. 180/2025 should be taken into account, and then a statement of compliance of the PPZ project with this recommendation should be sent to the Agency pursuant to Article 48aa(11) of the Act.
There is no need to modify the PPZ currently being implemented, which came into force before the publication of recommendation 180/2025. It is not possible to continue future editions of the PPZ in an unchanged form.